Skip to main content
Fig. 8 | BMC Biotechnology

Fig. 8

From: Impacts of loading thymoquinone to gold or silver nanoparticles on the efficacy of anti-tumor treatments in breast cancer with or without chemotherapeutic cisplatin

Fig. 8

Potentials of AuNPs or AuNPs composites on the level of serum CRP in EAC tumor-bearing mice. EAC-bearing mice were treated with PBS, CP, TQ, AuNPs, AgNPs AuNPs/TQ, ANPs/TQ, AuNPs/TQ + CP, or ANPs/TQ + CP daily for 6 successive days. The euthanasia of the mice occurred on the eleventh day subsequent to the inoculation of tumor cells. EAC cells were collected to assess their viability through the trypan blue method. The samples of sera were collected. Data are stated as mean ± SE (n = 5). A statistically significant difference between the groups was established at P < 0.05. a, b,c indicate statistically significant differences when compared to the naïve mice receiving PBS (a), EAC tumor-bearing mice receiving BPS (b)

Back to article page